Terumo Corp  

(Public, TYO:4543)   Watch this stock  
Find more results for 4543
4,145.00
-80.00 (-1.89%)
May 2 - Close
TYO data delayed by 20 mins - Disclaimer
Currency in JPY
Range 4,070.00 - 4,145.00
52 week 2,728.00 - 4,465.00
Open 4,085.00
Vol. 1.61M
Mkt cap 1.57T
P/E 34.45
Div/yield 19.00/0.84
EPS 120.32
Shares 375.74M
Beta     -
Inst. own     -
Aug 1, 2016
Q1 2017 Terumo Corp Earnings Release (Estimated) - 3:00PM GMT+9 - Add to calendar
Aug 1, 2016
Q1 2017 Terumo Corp Earnings Call (Japanese) (Estimated) Add to calendar
Jun 23, 2016
Terumo Corp Annual Shareholders Meeting (Estimated) - 2:00PM GMT+9 - Add to calendar
May 10, 2016
Full Year 2016 Terumo Corp Earnings Presentation (Japanese) - 4:15PM GMT+9 - Add to calendar
May 10, 2016
Full Year 2016 Terumo Corp Earnings Release - 3:00PM GMT+9 - Add to calendar
  

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 12.02% 7.86%
Operating margin 18.12% 12.23%
EBITD margin - 22.09%
Return on average assets 6.75% 4.22%
Return on average equity 11.31% 7.19%
Employees 19,934 -
CDP Score - 21

Address

2-44-1, Hatagaya
SHIBUYA-KU, TKY 151-0072
Japan
+81-3-33748111 (Phone)
+81-3-33748399 (Fax)

Website links

External links

Description

TERUMO CORPORATION is manufacturer of medical supplies. The Hospital Products segment is engaged in the manufacture, purchase and sale of hospital medical equipment, pharmaceuticals, peritoneal dialysis and diabetes related products, and the rental of hospital medical equipment and home medical products. The Cardiac and Vascular Area segment is involved in the manufacture, purchase and sale of catheter systems, artificial heart and lungs, as well as artificial blood vessels, the manufacture and sale of therapeutic coils for cerebral aneurysm, sampling equipment and kits for platelet-rich plasma and concentrated bone-marrow cell, and large-bore sheaths. The Blood System segment is engaged in the manufacture, purchase and sale of blood transfusion-related products. It also manufactures and sells healthcare related products. As of March 31, 2013, the Company had 79 subsidiaries and 2 associated companies.

Officers and directors

Yutaro Shintaku President, Chief Executive Officer, Representative Director
Age: 60
Ryo Nishihata Chief Financial Officer, Chief Accounting Officer, Senior Executive Officer, Director of Finance
Hiroshi Matsumura Executive Vice President, Representative Director
Age: 62
Hiroaki Kusukawa Chief Technology Officer, Executive Officer, Chief Director of Research & Development
Katsuya Takeuchi Chief Information Officer, Executive Officer, Director of Information Strategy
Takayoshi Mimura Senior Managing Executive Officer, Chairman & General Manager of Subsidiary, Director
Age: 62
Shinjiro Sato Managing Executive Officer, President of Cardiovascular Company, Director
Age: 55
Toshiaki Takagi Managing Executive Officer, Chief Quality Officer, Director
Age: 58
Shoji Hatano Managing Executive Officer, President of Hospital Company
Kazuaki Kitabatake Managing Executive Officer